Skip to content
Governance Register

← US public companies

Eagle Pharmaceuticals, INC.

SEC CIK 827871 · EGRX · last insider filing 2024-11-19

Directors (from insider filings)

NameCapacity as filedFilings
Tarriff Scott Director · President and CEO filed 2014 - 2024
Graves Michael Director · Interim Executive Chair & PEO filed 2014 - 2023
Ratoff Steven B Director filed 2014 - 2023
Simpson Jennifer K. Director filed 2019 - 2023
Glenning Robert Director filed 2016 - 2023
Edlin Richard A. Director filed 2017 - 2023
Borio Luciana Director filed 2021 - 2023
Pernock David Director · Pres. & Chief Comm. Officer filed 2015 - 2021
Braunstein Douglas L Director filed 2016 - 2019
Hudson Executive Capital LP Director filed 2019 - 2019
HEC Management GP LLC Director filed 2019 - 2019
Flaum Sander A Director filed 2014 - 2019
Moorin Jay Director filed 2014 - 2017
Schreiber Alain Director filed 2014 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Krawtschuk Christopher Chief Financial Officer filed 2024 - 2024
Cahill Brian Joseph Chief Financial Officer filed 2020 - 2024
Moran Michael Shawn EVP, Chief Commercial Officer filed 2021 - 2022
Ng-Cashin Judith Chief Medical Officer filed 2020 - 2021
Meyers Peter A. Chief Financial Officer filed 2017 - 2020
Hepner Adrian Executive VP filed 2015 - 2020
Krill Steven L. EVP & Chief Scientific Officer filed 2014 - 2018
Riggs David E Chief Financial Officer filed 2014 - 2017
Bruinenberg Paul Chief Medical Officer filed 2014 - 2014

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.